BIOGF
Price:
$0.66
Market Cap:
$27.24M
Biocartis Group N.V. is a molecular diagnostics firm dedicated to advancing clinical practice through innovative diagnostic solutions. These offerings aim to benefit patients, clinicians, healthcare payers, and the wider healthcare industry, with a particular emphasis on the field of oncology. Central to their product portfolio is the proprietary Idylla platform, a real-time polymerase chain reaction (PCR) system. This cutting-edge technology delivers vital molecular information, which is instrumental in both selecting appropriate treatments and continuously monitoring their effectiveness. The company provides a diverse array of Idylla tests, including mutation analyses for oncology biomarke...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2021-10-14
Stock Exchange
OTC
Ticker
BIOGF
According to Biocartis Group N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 1.65. This represents a change of -26.35% compared to the average of 2.24 of the last 4 quarters.
The mean historical Current Ratio of Biocartis Group N.V. over the last ten years is 4.82. The current 1.65 Current Ratio has changed 3.32% with respect to the historical average. Over the past ten years (40 quarters), BIOGF's Current Ratio was at its highest in in the June 2019 quarter at 13.26. The Current Ratio was at its lowest in in the January 2012 quarter at 0.
Average
4.82
Median
4.36
Minimum
1.65
Maximum
9.26
Discovering the peaks and valleys of Biocartis Group N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 126.43%
Maximum Annual Current Ratio = 9.26
Minimum Annual Increase = -48.06%
Minimum Annual Current Ratio = 1.65
| Year | Current Ratio | Change |
|---|---|---|
| 2022 | 1.65 | -41.63% |
| 2021 | 2.82 | -48.06% |
| 2020 | 5.43 | -41.33% |
| 2019 | 9.26 | 106.86% |
| 2018 | 4.48 | -46.85% |
| 2017 | 8.42 | 25.40% |
| 2016 | 6.72 | 58.57% |
| 2015 | 4.24 | 126.43% |
| 2014 | 1.87 | -43.55% |
| 2013 | 3.31 | -12.86% |
The current Current Ratio of Biocartis Group N.V. (BIOGF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.30
5-year avg
4.73
10-year avg
4.82
Biocartis Group N.V.’s Current Ratio is greater than Taihe Group, Inc. (0), less than Kiaro Holdings Corp. (0), greater than Elegance Optical International Holdings Limited (0.83), greater than SymBio Pharmaceuticals Limited (1.11), greater than RetinalGenix Technologies Inc. (0.00), greater than Goodness Growth Holdings, Inc. (1.20), greater than MCI Onehealth Technologies Inc. (0.44), less than Karolinska Development AB (publ) (128.29), less than Herantis Pharma Oyj (2.93), less than Oncopeptides AB (publ) (4.55),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0 | $71.85M | |
| 0 | $442.00 | |
| 0.83 | $63.38M | |
| 1.11 | $26.38M | |
| 0.00 | $75.37M | |
| 1.20 | $61.05M | |
| 0.44 | $54.04M | |
| 128.29 | $68.85M | |
| 2.93 | $59.47M | |
| 4.55 | $55.98M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biocartis Group N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biocartis Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Biocartis Group N.V.'s Current Ratio?
How is the Current Ratio calculated for Biocartis Group N.V. (BIOGF)?
What is the highest Current Ratio for Biocartis Group N.V. (BIOGF)?
What is the 3-year average Current Ratio for Biocartis Group N.V. (BIOGF)?
What is the 5-year average Current Ratio for Biocartis Group N.V. (BIOGF)?
How does the current Current Ratio for Biocartis Group N.V. (BIOGF) compare to its historical average?